Cover Image
市場調查報告書

Braasch Biotech LLC- 產品平台檢討

Braasch Biotech LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293940
出版日期 內容資訊 英文 19 Pages
訂單完成後即時交付
價格
Back to Top
Braasch Biotech LLC- 產品平台檢討 Braasch Biotech LLC - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 19 Pages
簡介

Braasch Biotech LLC是總公司設置於美國的生物科技企業。正在進行人體及動物的生物醫藥品及疫苗之藥物研發·開發·上市。對象疾病有肥胖,糖尿病性肥胖,兒的荷爾蒙障礙,IGF-1反應性神經病變等。此外也提供提升乳牛生產性的乳牛用疫苗。

本報告提供Braasch Biotech LLC的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,並彙整最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Braasch Biotech LLC的基本資料

  • Braasch Biotech LLC概要
  • 主要資訊
  • 企業資料

Braasch Biotech LLC:R&D概要

  • 主要的治療範圍

Braasch Biotech LLC:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Braasch Biotech LLC:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Braasch Biotech LLC:藥物簡介

  • JH-17
  • JH-18
  • Vaccine for Growth Hormone Deficiencies
  • Vaccine for Type 2 Diabetes

Braasch Biotech LLC:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Braasch Biotech LLC:最新的開發平台資訊

Braasch Biotech LLC:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06938CDB

Summary

Global Markets Direct's, 'Braasch Biotech LLC - Product Pipeline Review - 2015', provides an overview of the Braasch Biotech LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Braasch Biotech LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Braasch Biotech LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Braasch Biotech LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Braasch Biotech LLC's pipeline products

Reasons to buy

  • Evaluate Braasch Biotech LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Braasch Biotech LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Braasch Biotech LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Braasch Biotech LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Braasch Biotech LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Braasch Biotech LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Braasch Biotech LLC Snapshot
    • Braasch Biotech LLC Overview
    • Key Information
    • Key Facts
  • Braasch Biotech LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Braasch Biotech LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Braasch Biotech LLC - Pipeline Products Glance
    • Braasch Biotech LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Braasch Biotech LLC - Drug Profiles
    • JH-17
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • JH-18
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Growth Hormone Deficiencies
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Type 2 Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Braasch Biotech LLC - Pipeline Analysis
    • Braasch Biotech LLC - Pipeline Products by Target
    • Braasch Biotech LLC - Pipeline Products by Molecule Type
  • Braasch Biotech LLC - Recent Pipeline Updates
  • Braasch Biotech LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Braasch Biotech LLC, Key Information
  • Braasch Biotech LLC, Key Facts
  • Braasch Biotech LLC - Pipeline by Indication, 2015
  • Braasch Biotech LLC - Pipeline by Stage of Development, 2015
  • Braasch Biotech LLC - Monotherapy Products in Pipeline, 2015
  • Braasch Biotech LLC - Preclinical, 2015
  • Braasch Biotech LLC - Pipeline by Target, 2015
  • Braasch Biotech LLC - Pipeline by Molecule Type, 2015
  • Braasch Biotech LLC - Recent Pipeline Updates, 2015

List of Figures

  • Braasch Biotech LLC - Pipeline by Top 10 Indication, 2015
Back to Top